Legal & General Group PLC Homology Medicines, Inc. Transaction History

Legal & General Group PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.55 - $3.01 $5,197 - $10,092	-3,353 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$1.39 - $3.12 $42,882 - $96,255	-30,851 Reduced 90.2%	3,353 $7,000
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $79,020 - $168,896	21,709 Added 173.74%	34,204 $125,000
Q3 2021 Nov 15, 2021	BUY	$6.01 - $8.71 $44,071 - $63,870	7,333 Added 142.06%	12,495 $98,000
Q2 2021 Aug 12, 2021	BUY	$6.02 - $9.64 $3,912 - $6,266	650 Added 14.41%	5,162 $38,000

Q1 2021 May 17, 2021	SELL	$9.17 - $14.8 $1,347 - $2,175	-147 Reduced 3.16%	4,512 $43,000
Q3 2020 Nov 13, 2020	SELL	$9.94 - $16.59 $14,194 - $23,690	-1,428 Reduced 23.46%	4,659 $50,000
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $19,770 - $31,678	1,638 Added 36.82%	6,087 $92,000
Q1 2020 May 14, 2020	SELL	$12.5 - $22.04 $14,112 - $24,883	-1,129 Reduced 20.24%	4,449 $70,000
Q4 2019 Feb 13, 2020	BUY	$11.42 - $22.19 $11,911 - $23,144	1,043 Added 23.0%	5,578 $115,000
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $25,359 - $41,929	1,382 Added 43.83%	4,535 $89,000
Q4 2018 Feb 15, 2019	BUY	$18.39 - $26.3 $29,442 - $42,106	1,601 Added 103.16%	3,153 $71,000
Q2 2018 Aug 10, 2018	BUY	$16.49 - $21.55 $25,592 - $33,445	1,552 New	1,552 $32,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.